FENG, LILI,GONG, BAOQING,KARPINSKI, PIOTR H.,WAYKOLE, LILADHAR MURLIDHAR
申请号：
PE0014252013
公开号：
PE06982014A1
申请日:
2011.12.15
申请国别(地区):
PE
年份:
2014
代理人:
摘要：
Referring to a Crystalline form of 5 - Chloro - N2 - (2 - isopropoxi - 5 - methyl - 4 - piperidin-4-yl IL - phenyl) - N4 - [2 - (2 - propan-2-ol-hexane sulfonyl) phenyl] - pyrimidine - 2.4 - diamine having a Powder x-ray diffraction Pattern x which includes the diffraction Angle: 7,2\ufffd, 8,1\ufffd, 10,8\ufffd, 12,0\ufffd, 12,4\ufffd, 13,4\ufffd, 14 14,8\ufffd, 4th, among others (degrees two Theta).It also relates to a Pharmaceutical Composition and a preparation methodREFERIDA A UNA FORMA CRISTALINA DE LA 5-CLORO-N2-(2-ISOPROPOXI-5-METIL-4-PIPERIDIN-4-IL-FENIL)-N4-[2-(PROPAN-2-SULFONIL)-FENIL]-PIRIMIDIN-2,4-DIAMINA QUE TIENE UN PATRON DE DIFRACCION EN POLVO DE RAYOS X QUE COMPRENDE LOS ANGULOS DE DIFRACCION: 7,2�, 8,1�, 10,8�, 12,0�, 12,4�, 13,4�, 14,4�, 14,8�, ENTRE OTROS (GRADOS 2 THETA). TAMBIEN ESTA REFERIDA A UNA COMPOSICION FARMACEUTICA Y A UN METODO DE PREPARACION
